Home Regulatory Page 5

Regulatory

Pharma companies are not yet ready for the Brexit

3D printing, a disruptive technology still lacking regulatory guidance in the...

Αccelerated assessment of PRIority Medicines (the PRIME programme)

Redistribution of the UK centrally authorised product portfolio

Towards the harmonisation of clinical evaluation of medical devices

An update on orphan medicines and rare diseases

ICMRA: towards global standards for track-and-trace systems

The draft of the new Annex 1 is open to consultation

Regulatory challenges of CAR-T cell therapies

Many new clinical guidelines from EMA

1...345Page 5 of 5
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151